Medications

New FDA label bolsters safety case for Chantix

New government-approved labeling on Pfizer's drug Chantix suggests that the anti-smoking medication may not carry the risks of suicidal behavior that first earned it the Food and Drug Administration's strongest warning more ...

Psychology & Psychiatry

Robin Williams' death focuses attention on suicide

Each year, thousands of American adults commit suicide—39,518 in 2011, the most recent year for which data are available. But it took one suicide, that of actor/comedian Robin Williams, to focus attention on the problem ...

Attention deficit disorders

Dismisses link between suicidal behaviour and ADHD drugs

A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the ...

Psychology & Psychiatry

Promising biomarkers to predict suicide risk

In a Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Kees van Heeringen from Ghent University in Belgium and John Mann from Columbia University in the USA discuss the stress-diathesis ...

Medications

FDA reviews psychiatric side effects of Chantix

The U.S. Food and Drug Administration announced Friday it will convene a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer's anti-smoking drug Chantix.

Psychology & Psychiatry

Youthful suicide attempts a marker for lifelong troubles

A study that tracked more than 1,000 New Zealanders from birth to age 38 has found that those who attempted suicide before age 24 have been plagued by more health and psychiatric issues and had more economic difficulties ...

page 13 from 18